SARS-CoV-2 Spike receptor binding domain, RBD (395-430) – 0.5 mg

Overview

The SARS-CoV-2 Spike receptor binding domain (RBD), specifically residues 395-430, is a crucial component in studying the virus’s interaction with host cells. This peptide, derived from the spike protein of SARS-CoV-2, is vital for research focused on viral attachment and entry mechanisms. As a essential reagent, it’s ideal for developing therapeutic strategies and diagnostic assays aimed at COVID-19. You can easily incorporate this peptide into your research by purchasing it today.

Key Features

• High purity for reliable results
• Supports research on SARS-CoV-2 interactions
• Facilitates the development of vaccines and therapeutics
• Compatible with various biochemical assays
• Available in a convenient 0.5 mg size

Specifications

FAQ

What is the significance of the receptor binding domain?

The receptor binding domain (RBD) is crucial for the SARS-CoV-2 virus to attach to ACE2 receptors on human cells, which is the first step in the infection process.

How can I use this peptide in my research?

This peptide can be used in various assays, including binding studies, to evaluate the interactions between the virus and potential therapeutic compounds. You might also explore our PKG Substrate for additional assay applications.

Are there any storage requirements for this peptide?

Yes, it is recommended to store the peptide at -20°C and to avoid repeated freeze-thaw cycles to maintain its integrity.

Enhance your research capabilities by acquiring the SARS-CoV-2 Spike receptor binding domain today. This peptide is not just a tool but a key element in advancing your understanding of COVID-19 and developing effective countermeasures.

Related Products

• Autocamtide-2 [KKALRRQETVDAL]
• CREBtide [KRREILSRRPSYR], 5-FAM labeled

Browse more in Peptides.